| 1 | thrombosis and biofilm formation | | | | | | | 2 | 0.48% |
| 2 | omniphobic coating for medical | | | | | | | 2 | 0.48% |
| 3 | offers a unique slippery | | | | | | | 2 | 0.48% |
| 4 | preloader free flow medical | | | | | | | 1 | 0.24% |
| 5 | st louis boston childrens | | | | | | | 1 | 0.24% |
| 6 | israel deaconess hospital wayne | | | | | | | 1 | 0.24% |
| 7 | beth israel deaconess hospital | | | | | | | 1 | 0.24% |
| 8 | pittsburgh beth israel deaconess | | | | | | | 1 | 0.24% |
| 9 | of pittsburgh beth israel | | | | | | | 1 | 0.24% |
| 10 | boston childrens hospital university | | | | | | | 1 | 0.24% |
| 11 | louis boston childrens hospital | | | | | | | 1 | 0.24% |
| 12 | university of st louis | | | | | | | 1 | 0.24% |
| 13 | of st louis boston | | | | | | | 1 | 0.24% |
| 14 | hospital wayne state university | | | | | | | 1 | 0.24% |
| 15 | washington university of st | | | | | | | 1 | 0.24% |
| 16 | devices harvards wyss institute | | | | | | | 1 | 0.24% |
| 17 | medical devices harvards wyss | | | | | | | 1 | 0.24% |
| 18 | breakthrough medical devices harvards | | | | | | | 1 | 0.24% |
| 19 | develop breakthrough medical devices | | | | | | | 1 | 0.24% |
| 20 | to develop breakthrough medical | | | | | | | 1 | 0.24% |
| 21 | deaconess hospital wayne state | | | | | | | 1 | 0.24% |
| 22 | devices under development we | | | | | | | 1 | 0.24% |
| 23 | and top university research | | | | | | | 1 | 0.24% |
| 24 | device manufacturers while we | | | | | | | 1 | 0.24% |
| 25 | we welcome your device | | | | | | | 1 | 0.24% |
| 26 | devices we welcome your | | | | | | | 1 | 0.24% |
| 27 | following devices we welcome | | | | | | | 1 | 0.24% |
| 28 | the following devices we | | | | | | | 1 | 0.24% |
| 29 | on the following devices | | | | | | | 1 | 0.24% |
| 30 | we are currently focused | | | | | | | 1 | 0.24% |
| 31 | while we are currently | | | | | | | 1 | 0.24% |
| 32 | manufacturers while we are | | | | | | | 1 | 0.24% |
| 33 | medical device manufacturers while | | | | | | | 1 | 0.24% |
| 34 | under development we are | | | | | | | 1 | 0.24% |
| 35 | to medical device manufacturers | | | | | | | 1 | 0.24% |
| 36 | coating to medical device | | | | | | | 1 | 0.24% |
| 37 | provider and license our | | | | | | | 1 | 0.24% |
| 38 | technology provider and license | | | | | | | 1 | 0.24% |
| 39 | a technology provider and | | | | | | | 1 | 0.24% |
| 40 | are a technology provider | | | | | | | 1 | 0.24% |